These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 15191676

  • 1. [Association of uPA and uPAR expression with invasive behaviors of urinary transitional cell carcinoma].
    Li YJ, Zheng BZ, Zhou ZL.
    Ai Zheng; 2004 Jun; 23(6):704-6. PubMed ID: 15191676
    [Abstract] [Full Text] [Related]

  • 2. [The expression of urokinase-type plasminogen activator and its receptor in urinary transitional cell carcinoma].
    Li YJ, Zheng BZ, Zhou ZL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):57-9. PubMed ID: 14981816
    [Abstract] [Full Text] [Related]

  • 3. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V, Schroeder J, Denkert C, Kristiansen G, Schnorr D, Loening SA, Jung K, Staack A.
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [Abstract] [Full Text] [Related]

  • 4. Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.
    Casella R, Shariat SF, Monoski MA, Lerner SP.
    Cancer; 2002 Dec 15; 95(12):2494-9. PubMed ID: 12467062
    [Abstract] [Full Text] [Related]

  • 5. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V, Schroeder J, Kristiansen G, Roigas J, Denkert C, Johannsen M, Lein M, Loening SA, Schnorr D, Jung K, Staack A.
    Oncol Rep; 2005 Sep 15; 14(3):777-82. PubMed ID: 16077991
    [Abstract] [Full Text] [Related]

  • 6. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
    Ohba K, Miyata Y, Kanda S, Koga S, Hayashi T, Kanetake H.
    J Urol; 2005 Aug 15; 174(2):461-5. PubMed ID: 16006865
    [Abstract] [Full Text] [Related]

  • 7. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q, Liang LJ, Peng BG, Zhen YY.
    Ai Zheng; 2006 Nov 15; 25(11):1433-8. PubMed ID: 17094916
    [Abstract] [Full Text] [Related]

  • 8. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K, Nozaki S, Kitahara H, Kato K, Noguchi N, Kawashiri S, Yamamoto E.
    Oncol Rep; 2011 Dec 15; 26(6):1555-60. PubMed ID: 21833477
    [Abstract] [Full Text] [Related]

  • 9. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH, Wang C, Zhang YH, Yang YH, Zhan HY, Zhang LM.
    Zhonghua Yi Xue Za Zhi; 2007 Dec 04; 87(45):3228-32. PubMed ID: 18399120
    [Abstract] [Full Text] [Related]

  • 10. Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma.
    Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T.
    Cancer; 1998 Feb 15; 82(4):724-32. PubMed ID: 9477106
    [Abstract] [Full Text] [Related]

  • 11. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 15; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 13. [Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis].
    Wang WC, Wang Y, Sun CJ.
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun 28; 26(3):257-60. PubMed ID: 12536699
    [Abstract] [Full Text] [Related]

  • 14. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
    Wang L, Madigan MC, Chen H, Liu F, Patterson KI, Beretov J, O'Brien PM, Li Y.
    Gynecol Oncol; 2009 Aug 28; 114(2):265-72. PubMed ID: 19450871
    [Abstract] [Full Text] [Related]

  • 15. The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells.
    Iwamoto J, Mizokami Y, Takahashi K, Matsuoka T, Matsuzaki Y.
    Helicobacter; 2008 Jun 28; 13(3):174-82. PubMed ID: 18466392
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen activator system localization in 60 cases of ductal carcinoma in situ.
    Hurd TC, Sait S, Kohga S, Winston J, Martinick M, Saxena R, Lankes H, Markus G, Harvey S, Gibbs JF.
    Ann Surg Oncol; 2007 Nov 28; 14(11):3117-24. PubMed ID: 17701256
    [Abstract] [Full Text] [Related]

  • 17. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
    He Y, Liu XD, Chen ZY, Zhu J, Xiong Y, Li K, Dong JH, Li X.
    Clin Cancer Res; 2007 Jun 01; 13(11):3115-24. PubMed ID: 17545513
    [Abstract] [Full Text] [Related]

  • 18. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT, Cai ZM, Li NC, Na YQ.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 25; 86(28):1970-4. PubMed ID: 17064593
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA, Leaper DJ, Hayter JP, Dickenson AJ.
    Br J Oral Maxillofac Surg; 2007 Dec 25; 45(8):623-7. PubMed ID: 17590247
    [Abstract] [Full Text] [Related]

  • 20. Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis.
    Champelovier P, Boucard N, Levacher G, Simon A, Seigneurin D, Praloran V.
    Urol Res; 2002 Oct 25; 30(5):301-9. PubMed ID: 12389118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.